Dr. Cornelius Baur

Dr. Cornelius Baur appears in our data through filings on CTS Eventim AG & Co. KGaA shares, published by BaFin. The record holds 6 filings, for trades running from 12 September 2025 to 30 September 2026.

No open-market sale appears; the market trades are 6 purchases worth €950k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 5 purchases and no sales.

A typical purchase (the median) is worth €166k. Scaled by market value, the purchases weigh a median 0.0043% of market cap (sample: 5 purchases). 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 5 purchases with a full 90-day history, the hit rate stands at 20% and the median 90-day move at -0.5%. These figures describe past trades and do not predict future prices.

The latest filing, published on 1 October 2026, reports an open-market purchase of €100k in CTS Eventim AG & Co. KGaA. The median gap between a trade and its publication by BaFin is 5 days. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from BaFin disclosures alone and does not predict where the share price will go.